Curavit is a purpose-built to design and execute decentralized clinical trials.
Curavit has raised $5.0M in total funding. The most recent round was Series A. The last funding was announced in November 2022.
Curavit's investors include Osage Venture Partners, Royal Street Ventures, Narrow Gauge Ventures, Matt Wallach, Clark Golestani.
Curavit is headquartered in Boston, United States.
Curavit is a purpose-built to design and execute decentralized clinical trials.
Curavit is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Curavit — Funding & Investors." VCBacked, November 14, 2022, https://www.vcbacked.co/company/curavit. Accessed September 30, 2026.
VCBacked. (2022). Curavit — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/curavit
{{cite web |title=Curavit — Funding & Investors |url=https://www.vcbacked.co/company/curavit |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated